Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
The Oncologist|March 29, 2014
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcomaElizabeth R Plimack, Tingting Tan, Yu-Ning Wong, et al.
Targeted Oncology|March 29, 2022
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid TumorsAmita Patnaik, Shirish Gadgeel, Kyriakos P Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Amrita Sarkar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805Wendy J Bottinor, Yael Flamand, Naomi B Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trialCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.
European Urology|April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell CarcinomaSumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2015
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805Naomi B Haas, Judith Manola, Bonnie Ky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell CarcinomaWenxin Xu, Maneka Puligandla, Judith Manola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell CarcinomaNaomi B Haas, Leonard J Appleman, Mark Stein, et al.
Pageof 11